For cancer patients, high-quality communication with their doctors is key.
by Jessica Gorman
Can Genetic Ancestry Help Explain Cancer Risk? | The Cancer Genome Atlas | Carrying a Heavy Burden | Confronting Lung Cancer Stigma | Choosing End-of-Life Care | Guiding Patients From Screening Through Treatment | Vitamin E and Cancer Risk
Your Cancer Guide
This checklist can help you manage job issues during or after cancer treatment.
by Hester Hill Schnipper
Caregiving with Confidence
To care for your loved one, take steps to care for yourself.
by Michelle Johnston-Fleece
A survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
Drawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
Renewed interest in research about metabolism, the process cells use to fuel their growth, could lead to new types of cancer treatments.
by Stephen Ornes
Yesterday & Today
Even cancer couldn't slow down James Brown.
by Jocelyn Selim
Only one-third of new cancer therapies or drug combinations tested in phase III clinical trials prove to be better than the standard of care. Researchers explain why and how they are aiming to improve the odds.
by Sue Rochman
Finding support online is getting easier. Are these groups for you?
by Melissa Weber
Myra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
Going With the Grain | Walk the Walk
As first lady of Moldova, Margareta Timofti aims to increase cancer awareness and survival in one of Europe’s poorest nations.
On supporting teens with cancer, reducing cancer risk and having a child after cancer.
Breast cancer survivor AnneMarie Ciccarella discovered an interest in scientific research.
by Yvonne Lee
Julia Wiley, Tony Handler, Michael B. Lawing, Lori Petitti
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Can discussion of health inequities lead to actionable change?
by Marci A. Landsmann
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR